Publication:
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: a propensity score matched study

Thumbnail Image

Departments

School / College / Institute

Organizational Unit
Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU-Authors

KU Authors

Co-Authors

Siech, Carolin
Incesu, Reha-Baris
Morra, Simone
Scheipner, Lukas
Baudo, Andrea
Jannello, Letizia Maria Ippolita
de Angelis, Mario
Goyal, Jordan A.
Tian, Zhe
Saad, Fred

Publication Date

Language

Embargo Status

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Introduction: It is unknown whether the benefit from partial nephrectomy regarding lower other-cause mortality is applicable to older patients with metastatic renal cell carcinoma. Materials and methods: Using Surveillance Epidemiology and End Results database, patients with metastatic renal cell carcinoma, undergoing partial or radical nephrectomy, were stratified according to age (<60, 60-69, and >= 70 years). After propensity score matching, Kaplan-Meier survival analyses and multivariable Cox regression models were used. Results: Of 2,390 patients with metastatic renal cell carcinoma, 885 (37%) were aged <60 years, and 90 (10%) underwent partial nephrectomy; 824 (34%) were aged 60-69 years, and 61 (7%) underwent partial nephrectomy; and 681 (29%) were aged >= 70 years, and 64 (9%) underwent partial nephrectomy. After propensity score matching, in patients aged <60 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.22; p = 0.02); in patients aged 60-69 years, partial nephrectomy was associated with lower othercause mortality (hazard ratio 0.38; p = 0.03); but not in patients aged >= 70 years. Discussion: In metastatic renal cell carcinoma, partial nephrectomy is associated with lower other-cause mortality in patients aged <60 years and in patients aged 60-69 years, but not in patients aged >= 70 years. In consequence, consideration of partial nephrectomy might be of great value in younger metastatic renal cell carcinoma patients.

Source

Publisher

Elsevier Sci Ltd

Subject

Oncology, Surgery

Citation

Has Part

Source

Surgical Oncology-Oxford

Book Series Title

Edition

DOI

10.1016/j.suronc.2024.102047

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

5

Views

4

Downloads

View PlumX Details